Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Drug Makers Brace As Anti-Graft Campaign Impact Surfaces

Mixed Outlook

Executive Summary

Simcere, Hengrui, and Zai Lab are among the first Chinese pharma firms to report various forms of impact from the gathering storm of a national anti-corruption campaign launched in July in the healthcare and pharma sectors.

You may also be interested in...



Video Roundtable: APAC Team Talks Key Regional Trends And Topics

Join the Pink Sheet's APAC content team for a video overview of major trends and topics in the regional biopharma industry over the past few months.

Video Roundtable: APAC Team Talks Key Regional Trends And Topics

Join Scrip's APAC content team for a video overview of major trends and topics in the regional biopharma industry over the past few months.

China’s New Pharma Corruption Push Set For At Least A Year

As Beijing gets tougher in an all-out campaign to root out corruption and non-compliance in the pharma sector, more physician conferences are jeopardized and an increasing number of hospital presidents are placed under investigation. Meanwhile, one industry association issues new guidance for members. 

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC148936

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel